337 related articles for article (PubMed ID: 12145715)
1. Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study.
Kalmeijer MD; Coertjens H; van Nieuwland-Bollen PM; Bogaers-Hofman D; de Baere GA; Stuurman A; van Belkum A; Kluytmans JA
Clin Infect Dis; 2002 Aug; 35(4):353-8. PubMed ID: 12145715
[TBL] [Abstract][Full Text] [Related]
2. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections.
Perl TM; Cullen JJ; Wenzel RP; Zimmerman MB; Pfaller MA; Sheppard D; Twombley J; French PP; Herwaldt LA;
N Engl J Med; 2002 Jun; 346(24):1871-7. PubMed ID: 12063371
[TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage.
Doebbeling BN; Reagan DR; Pfaller MA; Houston AK; Hollis RJ; Wenzel RP
Arch Intern Med; 1994 Jul; 154(13):1505-8. PubMed ID: 8018006
[TBL] [Abstract][Full Text] [Related]
4. Intranasal mupirocin prophylaxis in elective surgery. A review of published studies.
Trautmann M; Stecher J; Hemmer W; Luz K; Panknin HT
Chemotherapy; 2008; 54(1):9-16. PubMed ID: 18063862
[TBL] [Abstract][Full Text] [Related]
5. A randomized clinical trial of mupirocin in the eradication of Staphylococcus aureus nasal carriage in human immunodeficiency virus disease.
Martin JN; Perdreau-Remington F; Kartalija M; Pasi OG; Webb M; Gerberding JL; Chambers HF; Täuber MG; Lee BL
J Infect Dis; 1999 Sep; 180(3):896-9. PubMed ID: 10438389
[TBL] [Abstract][Full Text] [Related]
6. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults.
Wertheim HF; Verveer J; Boelens HA; van Belkum A; Verbrugh HA; Vos MC
Antimicrob Agents Chemother; 2005 Apr; 49(4):1465-7. PubMed ID: 15793127
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review.
Laupland KB; Conly JM
Clin Infect Dis; 2003 Oct; 37(7):933-8. PubMed ID: 13130405
[TBL] [Abstract][Full Text] [Related]
8. Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study.
Wertheim HF; Vos MC; Ott A; Voss A; Kluytmans JA; Vandenbroucke-Grauls CM; Meester MH; van Keulen PH; Verbrugh HA
Ann Intern Med; 2004 Mar; 140(6):419-25. PubMed ID: 15023707
[TBL] [Abstract][Full Text] [Related]
9. Mupirocin treatment of nasal staphylococcal colonization.
Scully BE; Briones F; Gu JW; Neu HC
Arch Intern Med; 1992 Feb; 152(2):353-6. PubMed ID: 1739366
[TBL] [Abstract][Full Text] [Related]
10. Safety of targeted perioperative mupirocin treatment for preventing infections after cardiac surgery.
Shrestha NK; Banbury MK; Weber M; Cwynar RE; Lober C; Procop GW; Karafa MT; Gordon SM
Ann Thorac Surg; 2006 Jun; 81(6):2183-8. PubMed ID: 16731151
[TBL] [Abstract][Full Text] [Related]
11. Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients.
Lederer SR; Riedelsdorf G; Schiffl H
Eur J Med Res; 2007 Jul; 12(7):284-8. PubMed ID: 17933699
[TBL] [Abstract][Full Text] [Related]
12. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
[TBL] [Abstract][Full Text] [Related]
13. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients.
Boelaert JR; Van Landuyt HW; Godard CA; Daneels RF; Schurgers ML; Matthys EG; De Baere YA; Gheyle DW; Gordts BZ; Herwaldt LA
Nephrol Dial Transplant; 1993; 8(3):235-9. PubMed ID: 8385291
[TBL] [Abstract][Full Text] [Related]
14. Lack of efficacy of mupirocin in the prevention of infections with Staphylococcus aureus in liver transplant recipients and candidates.
Paterson DL; Rihs JD; Squier C; Gayowski T; Sagnimeni A; Singh N
Transplantation; 2003 Jan; 75(2):194-8. PubMed ID: 12548122
[TBL] [Abstract][Full Text] [Related]
15. Staphylococcus aureus infections in haemodialysis patients: pathophysiology and use of nasal mupirocin for prevention.
Boelaert JR; Van Landuyt HW; De Baere YA; Deruyter MM; Daneels RF; Schurgers ML; Matthys EG; Gordts BZ
J Chemother; 1995 Jul; 7 Suppl 3():49-53. PubMed ID: 8609538
[TBL] [Abstract][Full Text] [Related]
16. Reduction of preoperative conjunctival bacterial flora with the use of mupirocin nasal ointment.
Alexandrou TJ; Hariprasad SM; Benevento J; Rubin MP; Saidel M; Ksiazek S; Thompson K; Boonlayangoor S; Mieler WF
Trans Am Ophthalmol Soc; 2006; 104():196-201. PubMed ID: 17471340
[TBL] [Abstract][Full Text] [Related]
17. Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units.
Muller A; Talon D; Potier A; Belle E; Cappelier G; Bertrand X
Crit Care; 2005 Jun; 9(3):R246-50. PubMed ID: 15987397
[TBL] [Abstract][Full Text] [Related]
18. Preventing postoperative Staphylococcus infections: an update.
Grady M; Cullen JJ
Surg Technol Int; 2003; 11():57-60. PubMed ID: 12931284
[TBL] [Abstract][Full Text] [Related]
19. Elimination of Staphylococcus aureus in hemodialysis patients.
Bommer J; Vergetis W; Andrassy K; Hingst V; Borneff M; Huber W
ASAIO J; 1995; 41(1):127-31. PubMed ID: 7727815
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Staphylococcus aureus nasal carriers in CAPD with mupirocin.
Pérez-Fontán M; Rosales M; Rodríguez-Carmona A; Moncalián J; Fernández-Rivera C; Cao M; Valdés F
Adv Perit Dial; 1992; 8():242-5. PubMed ID: 1361797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
